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Vascular access and cardiac 
complications after PCI: In- and 
out-of-hospital outcome issues
rates for percutaneous coronary intervention (PCI) in Australia doubled while coronary artery bypass graft surgery rates declined by 12% in the years 
1993–2000 (Davies, 2003). Femoral artery puncture and 
sheath insertion is the most common form of arterial 
access for PCI. Management of the femoral artery puncture 
site and sheath removal is part of the role of cardiac 
nurses, not only in Australia, but also in the UK and other 
westernized countries. The traditional manual compression 
of the puncture site and the increasing variety of vascular 
closure devices have implications for nursing practice. 
Such devices maybe uncomfortable for the patient, time 
consuming for nurses, prolong hospitalization and carry 
the risk of vascular complications (Ruygrok and Chou, 
2005; Behan et al, 2007). 
Nursing studies have focused on the prevention and 
management of in-hospital vascular complications. Overall 
these rates ranged from 6.5% to 18% (Walker et al, 2001; 
Chlan et al, 2005). Even though these studies tracked com-
plications at 24 hours, they do not report out-of-hospital 
vascular complications. One study of recovery patterns in 
PCI patients reported puncture site pain in patients fol-
lowing discharge. The number of patients reporting punc-
ture site pain at 2 weeks was 4 (out of 37 patients); at 4 
weeks, 4 patients and 6 weeks, 2 patients. No other vascu-
lar complications were presented (Barnason et al, 2006)
Interestingly, the length of stay for PCI procedures has 
decreased in recent years, with cardiac nurses having less 
time to spend with the patient (Ruygrok and Chou, 2005). 
Knowledge of the clinical consequences or outcomes for 
the patient during recovery at home is rarely available for 
clinical nurses or hospital administrators. Therefore, it 
seems apparent that nurses need further information on 
the vascular and cardiac complications that patients 
encounter not only in the hospital but also out of the hos-
pital. This information will enable cardiac nurses to 
improve the monitoring of patient outcomes and improve 
their practice in PCI vascular management. Identifying 
information about out-of-hospital recovery complications 
or issues can assist cardiac nurses to enhance in-hospital 
patient education on what to expect and what actions to 
take should post-recovery complications occur, and also 
to augment appropriate support services.
Finally, even though this study took place in Australia, 
health care practices are similar enough for these results to 
have significance for nurses working in the UK and other 
countries. 
Background
The research institution is a 200-bed large urban acute 
hospital centre that carries out approximately 500 PCI 
procedures annually. The majority of PCI procedures were 
conducted via the femoral artery, with only a very small 
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Abstract
Background: Despite the rapid increase in percutaneous coronary 
intervention (PCI) rates, vascular complications remain a possible 
source of impaired outcomes for patients. Moreover, management of 
complications is an integral part of cardiac nurses’ roles and 
responsibilities.
Aim: The aim of this quality review was to highlight the in-hospital 
and out-of-hospital complications up to 2 months post-discharge 
following PCI. 
Methods and Results: A review of prospectively-collected data 
from the Angioplasty Database run by the research institute of 089 
consecutive patients who had PCI procedures from  January 2005–
3 December 2006 was conducted. The in-hospital vascular 
complications included bleeding/ooze only (22.4%) and haematoma 
only (7.%). The in-hospital cardiac outcomes included one death 
(0.09%) following PCI. In addition, a sample of 525 (52%) patients 
were followed up at  month and 2 months post-procedure. 
Vascular complications were 2.5% and 4% respectively. Cardiac 
complications included repeat angiogram (9.7%) and repeat PCI 
(3.6%).
Conclusions: Vascular outcomes pose ongoing problems for 
patients both in and out of hospital. The results suggest that cardiac 
nurses need to further improve monitoring of their patient outcomes 
following PCI. 
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number performed via the radial artery approach. This is 
consistent with national and international trends. 
Registered Nurses who had completed the education and 
competency program were endorsed to remove femoral 
sheaths. The nurses removed the femoral sheath when the 
activated clotting time was less than 150–170 seconds; 
usually 3–4 hours after return to the unit.
It was standard practice at the research institution for 
patients to receive oral antiplatelet medications (ticlopi-
dine or clopidogrel) ahead of the procedure. The loading 
dose could be up to 600 mg. These medications continued 
for at least 1 month, usually 12 months or indefinitely post 
PCI. The use of intravenous glycoprotein IIb/IIa inhibitors 
(abciximab, tirofibian) was also recorded. The patient was 
usually discharged the morning after the PCI, following an 
education session delivered by registered nurses from the 
unit. It is usual practice to follow up patients by telephone 
at 1 month and 12 months.
Aims
The aim of this project was to highlight, through data from 
in-hospital surveys and telephone follow up, the ongoing 
complications experienced up to 12 months after PCI. The 
following questions were examined:
w What is the incidence of in-hospital vascular complica-
tions and cardiac complications post-PCI?
w What is the reported incidence of out-of-hospital vascu-
lar complications and cardiac complications in the first 
1 month and 12 months following PCI?
w Identify ways that nurses can enhance the discharge and 
recovery management of patients post-PCI.
Methods
Study design and subjects
This was a review of prospectively collected data from the 
Angioplasty Database run by the research institute of 1089 
consecutive patients who had PCI procedures 
carried out over the 2 year period from 1 January 2005 to 
31 December 2006. 
Study protocol 
Data were collected from patients post-PCI on return to 
the cardiology unit or the cardiac surgical unit. Nurses 
completed an Angioplasty Database form for all post-PCI 
patients. This form included information about patient 
demographics, indication for the procedure, closure device 
used and complications experienced. Data were subse-
quently entered into the Angioplasty Database by the 
interventional cardiology research nurse. This research 
nurse also conducted the telephone follow-up interviews 
with patients at 1 month and 12 months post-discharge. 
These interviews provided information on mortality and 
morbidity, ongoing vascular complications and cardiac 
symptoms.
In this review we define in-hospital vascular complica-
tions as haematoma, bleeding/ooze at the puncture site, 
pseudoaneurysm and retroperitoneal haematoma. The 
presence of a haematoma was recorded alongside the 
length and width (in cm) of the haematoma. ‘Bleeding/
ooze at the puncture site’ referred to bleeding or oozing 
that arose from the groin wound post-PCI. The definition 
did not differentiate between arterial and venous bleeding. 
Pseudoaneurysm was defined as an area of local swelling 
and/or presence of bruit on auscultation, confirmed by 
ultrasound or Doppler study. 
Data were recorded on groin complications via the tel-
ephone follow-up at 1 month and 12 months. These symp-
toms included: pain in the groin, haematoma still present, 
bruising and numbness in the area. Also, any patient 
reports of out-of-hospital treatment for pseudoaneurysm 
were recorded. Patients’ reports included treatments such 
as surgical repair, thrombin closure, ultrasound and any 
other related procedures. For cardiac events, the telephone 
interview provided data from either the patient or family 
regarding death, myocardial infarction, stroke, the need 
for repeat PCI, and coronary artery bypass graft surgery 
required.
Ethical approval and statistical analysis
Ethical approval was granted by the UnitingCare Health 
Human Research Ethics Committee. The researchers did 
not contact individual patients for consent to review the 
database, as patients had already signed a form on admis-
sion, consenting to the collection and use of their 
personal information. This was a descriptive study, 
presented as summaries (e.g. percentages and means, 
standard deviations or medians) of the patient and proce-
dure characteristics. 
Results
Demographic and baseline data
The results report the outcomes of 1089 procedures car-
ried out over a 2 year period. There were 548 procedures 
n = 027
Variable n %
Male 767 74.7
Female 260 25.3
Hypertensive 77 69.8
Diabetic 233 22.7
Hyperlipidaemia 600 58.4
Family history 250 24.3
Smoker 4 3.7
Stable angina 445 43.3
Unstable angina 333 32.4
Post-MI 78 7.3
Acute MI 39 3.8
rescue acute MI 4 0.4
MI = myocardial infarction
Table 1.
Patient characteristics
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in 2005 and 541 in 2006, conducted on a total of 1027 
patients (526 in 2005 and 501 in 2006). There were 971 
patients with one procedure recorded in the data base for 
this 2 year period. There were 50 patients who had 2 
recorded procedures and 6 patients had 3 recorded proce-
dures. The patient characteristics, comorbidities and chest 
pain status are recorded in Table 1.
Almost three-quarters of the patients were men. The 
median age of the patient group was 67 years, ranging 
from 34 to 91 years. The majority of patients, not surpris-
ingly, had noted risk factors for coronary artery disease. 
The most prevalent comorbidities were hypertension 
(69.8%) and hyperlipidaemia (58.4%). 
In-hospital vascular complications
Of the 1089 procedures 389 (35.7%) were recorded as 
experiencing vascular complications. The incidence of 
vascular complications is contained in Table 2. Worthy of 
note is the 22.4% incidence of bleeding/ooze only and 7% 
haematoma only.
The vascular complications (n=389) were further 
broken down by the closure devices used immediately 
after the PCI (Table 3). The Angio-Seal device and digital 
pressure were the most commonly used closure methods. 
Of the 184 procedures where Angio-Seal was used, 70.1% 
had bleeding/ooze only and 15.8% had bleeding/ooze and 
haematoma. For patients where the sheath/digital pressure 
approach was used (n=171) 55% had bleeding/ooze only 
and 15.8% had haematoma and bleeding/ooze. Sheath/
digital pressure recorded a 28.6% haematoma rate.
The angioplasty database form traced the time nurses 
were spending in managing bleeding/ooze and their 
choice of intervention. Bleeding/ooze with or without 
haematoma was recorded in 309 of the 389 vascular com-
plications. The majority of the bleeding was controlled in 
less than 30 minutes in 103 cases (62.8%). Control of 
bleeding was gained within 31 minutes to 2 hours in 64 
procedures (20.7%). Control of bleeding taking longer 
than 2 hours occurred in 51 procedures (16.5%). The 
nurses’ choice of intervention was application of digital 
pressure or use of the FemStop device. Digital pressure 
alone was used in 43% of the 309 cases. The FemStop 
device alone was used in 28% of cases and a combination 
of both devices in 26% of cases.
The nurses’ treatment of haematoma was also tracked 
via the database. Haematoma with or without bleeding/
ooze occurred in 143 of the 389 procedures with vascular 
complications recorded. Digital pressure alone was applied 
in 50% of the procedures, while FemStop alone was 
applied in 18% of cases. A combination of digital pressure 
and the FemStop device was used in 20.3% of cases. 
However, the tool did not track the time that nurses were 
spending managing haematoma. 
The length and width of haematoma was also recorded 
using the data collection tool. The haematoma size was 
recorded in only 103 out of 143 procedures where a hae-
matoma was formed. The median length and width of the 
haematoma was 3 cm.
All procedures n = 089 
Vascular complication Procedures 
 n (% of total)
All complications 389 (35.7%)
Bleeding/ooze only 244 (22.4%)
Haematoma only 77 (7.%)
Bleeding/ooze and haematoma 65 (6%)
Ultrasound diagnosis  2 (0.37 %) 
of pseudoaneurysm
Haematoma and nil treatment   (0.%) 
for pseudoaneurysm
Table 2.
Vascular complications
(n=389)
    Haematoma and    
 Bleeding/ Haematoma  Bleeding/ooze  pseudoaneurysm Pseudoaneurysm   
Closure method ooze only  only  and haematoma (nil treatment) (ultrasound)  Total
Perclose 2 (66.7) 0  (33.3)   3 (00)
Angio-Seal 29 (70.) 24 (3) 29 (5.8)  2 (.) 84 (00)
Digital pressure 94 (55) 49 (28.6) 27 (5.8)  (0.6)  7 (00)
radiStop 2 (00) 0 0   2 (00)
Other 5 (60) 3 (2) 7 (28)   25 (00)
Not specified 2 (50)  (25)  (25)   4 (00)
Table 3.
Vascular complications by closure device
As is often the case, the data collected on length of stay 
is highly skewed and so the median estimate is used as a 
summary: total length of stay was 2 days (range 0–4 days), 
with post-procedural length of stay being 1 day (range: 
0–32 days)(Lee et al, 2003). The median length of stay of 
2 days is similar to that reported nationally in Australia 
(Davies, 2003). There was no difference in the median 
estimates of length of stay between patients who had a 
vascular complication and those who did not.
In-hospital cardiac complications post-PCI
The number of in-hospital cardiac complications included 
the use of the intra-aortic balloon pump for 12 (1.1%) of 
the 1089 procedures, and a blood transfusion in two cases 
(0.2%). There was 1 (0.1%) reported death following PCI 
and 3 deaths (0.3%) during the same hospital admission. 
There was no incidence of coronary artery bypass graft 
surgery or acute myocardial infarction as a result of PCI. 
There were 17 incidences (1.56%) recorded as ‘other’ 
where no further details were given.
Out-of-hospital vascular and cardiac 
complications occurring within 1 month and 
12 months after discharge
Patients who underwent PCI in 2005 (525) were 
telephoned at 1 month and between 2–12 months post-
discharge. The data for the 2006 patients was not included 
as, at the time of writing, not all patients had been 
followed-up at 12 months. 
The cardiac and vascular follow-up data are presented in 
Table 4. Interestingly, groin complications presented 
ongoing problems for patients, with a 2.5 % incidence at 
1 month and total of 4% incidence at 12 months. Owing to 
low numbers formal assessment of any associations 
between groin complications at 1 month and 12 months 
and patient characteristics is difficult.
Cardiac issues were also ongoing throughout the first 
12 months after discharge. The incidence of all causes of 
death at 12 months was 3%. Events that required re-
admissions to hospital over the 12 months included repeat 
angiogram 9.7%, repeat angioplasty 3.6% and coronary 
artery bypass graft surgery 1.3%. 
Discussion
The major finding of this review is that vascular complica-
tions are ongoing problems for patients both in and out of 
hospital. Overall, the incidence of in-hospital vascular 
complications was considerable at 35% (389 of 1089 pro-
cedures). Moreover, bleeding/ooze and haematoma were 
the two most common problems experienced by patients 
following PCI.
Digital pressure for sheath removal and the Angio-Seal 
device were the predominant methods of obtaining 
haemostasis. The Angio-Seal device was associated with 
more bleeding/ooze and fewer cases of haematoma in 
comparison with digital pressure with femoral sheath 
removal. However, femoral sheaths were associated with 
more haematomas and fewer bleeding/ooze episodes 
compared with the Angio-Seal device. 
Some caution needs to be taken as nurses’ reports of 
bleeding/ooze may at times have only been venous ooze 
rather than actual arterial bleed. Further, there may have 
been an over-reporting of bleeding owing to the broad 
definition given. Major bleeding reported may have been 
over-represented in comparison with minor bleeding, 
which includes subcutaneous capillary ooze from the 
Angio-Seal device. Angio-Seal manufacturer guidelines 
recommend that nurses monitor for subcutaneous tract 
ooze (St Jude Medical, 2007), though it is unclear from the 
data collected what was tract ooze and what was major 
bleeding. So it seems apparent that this should be addressed 
with future data collection. 
One study of 10 669 PCI patients noted only a 10.27% 
incidence of in-hospital vascular complications 
(Kuchulakanti et al, 2004) whereas in this study a signifi-
cant 35% of patients experienced vascular complications. 
Kuchulakanti et al (2004) also identified haematoma as the 
most common vascular complication whereas the current 
report identified bleeding/ooze as the most common.
Problems were noted in this review with the recording 
of haematoma size (length and width). Data were only 
available for 103 out of 143 procedures because there were 
inconsistencies in completing this section of the angio-
plasty database form. The data collection form required 
the nurse to tick a box if a haematoma was present, and 
4 British Journal of Cardiac Nursing    ????? 2008    Vol 3 No ?
Research and Development
(n=525)
 1 month 12 month 
Outcome follow-up  follow-up
Death 5 (.0%) 6 (3.0%)
MI  (0.2%) 2 (0.4%)
Stroke 2 (0.4%) 7 (.3%)
Cardiac rehab 344 (65.5%) 449 (85.4%)
repeat angiogram 9 (.7%) 5 (9.7%)
repeat angioplasty 6 (.%) 9 (3.6%)
repeat lesion 0 8 (.5%)
repeat vessel 3 (0.6%) 7 (.3%)
CABG 3 (0.6%) 7 (.3%)
Groin complications 3 (2.5%) 2 (4.0%)
Surgical repair  (0.2%) 2 (0.4%)
Thrombin close 0 0
Ultrasound 0 0
Other  (0.2%) 3 (0.6%)
Angina 45 (8.6%) 97 (8.4%)
CABG = Coronary artery bypass graft surgery
Table 4.
Telephone follow-up data for patients 
undergoing PCI in 2005 
March 3
then record the size (length and width). However, in 
28% of cases the haematoma box was ticked but no size 
was recorded, or the size was recorded but no haematoma 
was noted. 
The issue of inadequate definitions is also represented in 
the literature. In their meta-analysis of vascular complica-
tions, Nikolsky et al (2004) reported 30 studies which 
noted haematoma development. The haematoma sizes 
ranged from <5cm, 2–6cm, 5–10cm, >10cm, >20cm to 
any palpable mass requiring blood transfusion and pro-
longing hospitalization. Nikolsky et al (2004) noted that 
the definition criteria for haematoma were so wide that it 
was excluded as a primary end point in analysis.
Vascular complications continued after discharge for 
the post-PCI patient. While most of the groin complica-
tions tabled, above occurred within the first month after 
discharge (2.5%), a surprising 1.5% of patients reported 
ongoing symptoms for up to 12 months after discharge. 
Clearly, the short length of hospital stay for a PCI 
procedure does not equate to a short-term problem for 
the patient. Discharge from hospital for some patients 
represents ongoing problems over the first 1–12 months 
post PCI. For cardiac nurses there is a need for out-of-
hospital telephone follow-up service to continue to sup-
port patients post-PCI. Not only will information gained 
at follow-up better inform nurses about their patients, 
but it will provide feedback to inform future patients of 
what to expect when they go home following PCI.
There is support in the literature for better monitoring 
of patients following any cardiac procedure. Kuchulakanti 
et al (2004) point to the ongoing nature of cardiac and 
vascular complications reported via telephone follow-up 
of patients post-PCI. Furthermore, reported vascular 
complications were a significant predictor of mortality at 
12 months. They called for diligent efforts to minimise 
vascular complications and to follow up patients in case of 
future coronary events (Kuchulakanti et al, 2004) 
Similarly, there are cardiac issues that represent an 
ongoing problem for some patients, such as repeat angi-
ogram, angioplasty or coronary artery bypass graft surgery 
(Kuchulakanti et al, 2004). All of these procedures entail 
readmissions to hospital that are often associated with 
anxiety for the patient and family. They also carry addi-
tional procedural risks, and involve an extended recovery 
period. Clearly, for a small group of patients; the 2–3 day 
angioplasty hospitalization may not be the end of their 
treatment experiences. 
Limitations 
The major limitations of this report result from the use of 
a retrospective analysis of data obtained via the Angioplasty 
Database and the lack of reliability testing of the data 
stored in the database. The report highlights data quality 
issues, like the lack of clear definitions for aspects of data 
collected. As such, this made the interpretation of aspects 
of the data difficult. Feedback has been provided about the 
data collection tool and the data elements are currently 
being defined and the tool has been upgraded. 
The lack of consistent recording of haematoma size by 
the nurses has been previously identified. Without 
adequate documentation on haematoma size this review 
cannot provide an evaluation of performance in terms of 
how significant those haematomas may have been.
Implications for nursing practice and 
further research
This report has highlighted that ongoing cardiac and 
vascular issues exist for a certain percentage of patients 
after discharge following PCI. These were associated with 
repeat readmission to hospital and exposed the patient to 
the risks and anxiety associated with further medical 
interventions. Nurses need to consider the content of their 
teaching plans in order to better prepare the patient and 
family to monitor and deal with possible vascular and 
cardiac complications following PCI procedures. 
This report has recognized the value of the out-of- 
hospital telephone support service in not only monitoring 
and tracking longer-term patient outcomes but also the 
individual counselling benefits that talking with an expert 
nurse can provide. Given the short length of stay and 
ongoing complications associated with PCI, it is recom-
mended that all institutions offer a nurse-led telephone 
support service for their patients and families. The short 
length of stay means that patients are left to recover at 
home without the added support of experienced cardiac 
nurses. The organization where the study was undertaken 
is situated in a large city with many patients coming in 
from rural areas, who have limited access to cardiac 
specialist nurses in their communities. The introduction 
of out-of-hospital support services would greatly 
assist patients in the recovery phase and augment local 
medical services.
It is recommended that the interventions nurses use to 
treat bleeding/ooze and haematoma be more clearly 
defined and recorded with a view to develop a risk assess-
ment tool. For example, interventions such as the applica-
tion of digital pressure or the Femstop device for more 
than 30 mins could be used as an indicator to develop a 
stratification of mild, moderate or high-risk alert for the 
patient developing a more serious vascular complication, 
such as pseudoaneurysm. This type of tool could be ben-
eficial for organizations employing more nurses who are 
new to the cardiac nursing specialty. It would assist in 
detecting high-risk patients.
Finally, further research is needed to address the varia-
ble size of haematoma definitions used by the institution 
under review. A research project could aim to produce a 
standardized assessment tool that would measure the size 
of the haematoma and correlate this with the volume of 
blood contained in the haematoma (by ultrasound). These 
findings could then be linked to clinical consequences for 
the patient. 
Conclusions
The review has identified that femoral vascular and 
cardiac complications represented ongoing issues for 
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groups of patients in and outside hospital after PCI. Out-
of-hospital telephone support services are required to 
monitor such complications and to better provide support 
for the patients and families during recovery. 
Review of in-hospital and out-of-hospital vascular 
complications has provided a baseline awareness of the 
standards of nursing practices. Raised awareness should 
further empower nurses to participate in better data 
collection and recording and be involved in pertinent 
research endeavours to augment more appropriate sup-
port services for their cardiac patients.
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